GC
VXRT

Globeflex Capital’s Vaxart VXRT Stock Holding History

Globeflex Capital’s Portfolio VXRT Stock Details VXRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-56
Closed -$1K – 538
2016
Q3 		$1K Buy
+56
New +$886 ﹤0.01% 427
2015
Q3 		– Sell
-15
Closed – – 574
2015
Q2 		$0 Hold
15
– – ﹤0.01% 589
2015
Q1 		$0 Buy
+15
New +$413 ﹤0.01% 599

Other funds holding VXRT

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
GCIA
Gabelli & Co Investment Advisers Rye, New York $674M AUM 64.52% 1-Year Est. Return

Globeflex Capital's VXRT Position: Q4 2016 in Review

Globeflex Capital sold out of Vaxart (VXRT) in Q4 2016, closing a stake of 56 shares — an estimated $1K sold.

Globeflex Capital first reported a position in VXRT in Q1 2015 and held it in 3 quarters. The position peaked at $1K in Q3 2016. 45 funds tracked by Wall St. Rank hold VXRT as of Q4 2016.

  • Globeflex Capital reported no remaining Vaxart position as of Q4 2016 after selling out during the quarter.
  • Globeflex Capital sold 56 Vaxart shares in Q4 2016, an estimated $1K.
  • Globeflex Capital first reported a position in Vaxart in Q1 2015 and held it in 3 quarters.
  • Globeflex Capital's Vaxart position peaked at $1K in Q3 2016.
  • 45 funds tracked by Wall St. Rank held Vaxart as of Q4 2016.

Based on Globeflex Capital's 13F filing for Q4 2016, filed 13 Feb 2017.